Brenntag Specialties Pharma offering phosphate-based excipients by Budenheim
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
It is intended for contrast enhancement in MRI scans
This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral portfolio
Genomics is transforming the future of modern medicine and treatment modalities across specialties
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
The company expects to launch this product through its marketing partner in the near future
Subscribe To Our Newsletter & Stay Updated